CFO of Quantum‑Si Sells 4,233 Shares in Routine RSU Move as Stock Slides – Insider Buying Continues Amid Volatility

Quantum‑Si Insider Activity: A Close‑Up on Keyes Jeffry R. and the CFO’s Recent Sell‑to‑Cover

Sell‑to‑Cover Moves and Market Sentiment On March 20, 2026 the CFO of Quantum‑Si, Keyes Jeffry R., sold 4,233 shares of Class A common stock as part of a mandatory sell‑to‑cover provision tied to the vesting of restricted stock units. The shares were sold at an average price of $0.85, just shy of the current market price of $0.898. While the transaction itself is routine for RSU holders, the timing coincides with a sharp decline in the stock’s weekly performance (‑8.3 %) and a 278 % spike in social‑media buzz, indicating heightened investor attention. The sentiment score of +74 suggests that the broader community remains largely upbeat despite the stock’s recent slide, but the buzz intensity hints that traders are watching the CFO’s activity closely.

Implications for Investors and Corporate Outlook Sell‑to‑cover transactions are standard practice and do not necessarily signal a lack of confidence from insiders. However, the CFO’s continued sell‑to‑cover activity—paired with the recent share purchases of 652,803 shares earlier in March—shows a balanced approach: he is harvesting gains while also maintaining a significant stake (approximately 1.81 million shares post‑transaction). For investors, this pattern may be interpreted as a prudent risk‑management strategy rather than a sign of looming liquidity concerns. That said, the company’s price has been on a downtrend for the year (‑38.6 %) and the P/E ratio is negative, underscoring the need for caution as Quantum‑Si navigates the competitive protein‑sequencing market.

A Profile of Keyes Jeffry R.: Transaction Patterns and Strategic Position Keyes Jeffry R. has been active in Quantum‑Si’s equity since at least December 2025. His first recorded move was a sale of 8,627 shares at $1.28 in December 2025, followed by a sizeable purchase of 652,803 shares at no cost in March 2026—likely a grant of RSUs that he later exercised. He also exercised a stock‑option grant of 780,847 shares at no price. In March 2026, he sold two batches of shares (4,233 and 4,422 shares) at $0.85 and $0.83, respectively, both under sell‑to‑cover provisions. These transactions demonstrate that Keyes tends to lock in gains once RSUs vest, while simultaneously investing in the company’s equity base. His overall holding of roughly 1.8 million shares—about 9 % of outstanding shares—positions him as a significant long‑term stakeholder.

Company‑Wide Insider Activity Context The CFO’s activity mirrors broader insider movements: the president, CEO Hawkins Alan, and the GC & Corp. Secretary LaPointe Christian both executed two sell transactions each in late March. These coordinated moves suggest a pattern of periodic liquidity events rather than a coordinated sell‑off. The collective sell volume is modest relative to the company’s market cap (~$193 M), indicating that insider confidence remains relatively intact.

Bottom Line for Market Participants Keyes Jeffry R.’s latest sell‑to‑cover transaction is a normal part of RSU management and does not appear to foreshadow a decline in corporate performance. Investors should, however, remain mindful of the company’s volatile price action and negative earnings multiples. Continued monitoring of insider transactions, especially the CFO’s balanced buying and selling, will provide useful insight into long‑term confidence as Quantum‑Si pursues its innovative protein‑sequencing platform.